Publications by authors named "J A Minke"

dsRNA-dependent protein kinase R (PKR) is a key factor of innate immunity. It is involved in translation inhibition, apoptosis, and enhancement of the proinflammatory and IFN responses. However, how these antiviral functions are conserved during evolution remains largely unknown.

View Article and Find Full Text PDF

Background: Viperin, also known as radical S-adenosyl-methionine domain containing protein 2 (RSAD2), is an interferon-inducible protein that is involved in the innate immune response against a wide array of viruses. In mammals, Viperin exerts its antiviral function through enzymatic conversion of cytidine triphosphate (CTP) into its antiviral analog ddhCTP as well as through interactions with host proteins involved in innate immune signaling and in metabolic pathways exploited by viruses during their life cycle. However, how Viperin modulates the antiviral response in fish remains largely unknown.

View Article and Find Full Text PDF
Article Synopsis
  • Cytotoxic T-lymphocytes (CTLs) play a crucial role in protecting against equid herpesvirus type 1 (EHV-1), but the specific target proteins for these immune cells are not well understood.
  • A study found that horses with certain genetic markers (ELA-A2 and ELA-A3 haplotypes) produced CTL responses to a protein called the immediate-early (IE) protein after being infected with EHV-1 or vaccinated with a modified virus.
  • Since the ELA-A2 and ELA-A3 haplotypes are common in popular horse breeds like Thoroughbreds, the IE protein is a promising target for developing future vaccines.
View Article and Find Full Text PDF

Dogs account for the majority of human exposures and deaths due to rabies virus (RABV) worldwide. In this report, we show that a replication-deficient RABV-based vaccine in which the matrix gene is deleted (RABV-ΔM) is safe and induces rapid and potent VNA titers after a single inoculation in dogs. Average VNA titers peaked at 3.

View Article and Find Full Text PDF

West Nile virus (WNV) is an emergent pathogen in the Americas, first reported in New York during 1999, and has since spread across the USA, Central and South America causing neurological disease in humans, horses and some bird species, including domestic geese. No WNV vaccines are licensed in the USA for use in geese. This study reports the development of a domestic goose vaccine efficacy model, based on utilizing multiple parameters to determine protection.

View Article and Find Full Text PDF